Clinical Trial

Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial

Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study was to further improve the clinical efficacy of acupuncture in delaying the clinical recurrence of CD and to explore the efficacy mechanism of acupuncture efficacy enhancement.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-08-10; most recent amendment 2026-04-07.
Status change: Not Yet Recruiting → Recruiting 2024-08-13
Trial Details
NCT Number NCT06553053
Lead Sponsor Shanghai Institute of Acupuncture, Moxibustion and Meridian
Collaborators: Ruijin Hospital
Conditions Crohn's Disease Relapse, Inflammatory Bowel Diseases
Enrollment 106 participants
Start Date 2024-08-13
Primary Completion 2028-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-13